The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face
The Evaluation of the Safety and Effectiveness of a Novel Gel-Type Sodium Hyaluronate for the Correction of Aging Mid-Face
Sponsor: SciVision Biotech Inc.
Listed as NCT04599335, this NA trial focuses on Aging Mid-Face and Dermal Filler and remains completed. Sponsored by SciVision Biotech Inc., it has been updated 12 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
-
Aug 2023 — Nov 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2023 — Aug 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Mar 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2021 — Mar 2022 [monthly]
Recruiting NA
-
Mar 2021 — Oct 2021 [monthly]
Recruiting NA
-
Feb 2021 — Mar 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- SciVision Biotech Inc.
For direct contact, visit the study record on ClinicalTrials.gov .